Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

Dan Rather Reports Investigates our Heavy Dependence on Antibiotics - What are the Causes... and the Consequences?

January 11, 2011 7:36 am | by Bio-Medicine.Org | News | Comments

DALLAS, Jan. 11, 2011 /- Tonight's "Dan Rather Reports" examines the alarming health consequences resulting from the overuse of antibiotics. Every year, more than 90,000 Americans die from "superbugs" that antibiotics cannot treat; these antibiotic-resistant infections, caused directly by...

BioMarin Initiates Phase 1/2 Trial for BMN 673 for the Treatment of Genetically-Defined Cancers

January 11, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

NOVATO, Calif., Jan. 11, 2011 /- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced the initiation of a Phase 1/2 trial for BMN 673, a poly ADP-ribose polymerase (PARP) inhibitor in development for the treatment of genetically-defined cancers.   "PARP inihibtors have been...

Virtual Radiologic Ranked #1 for Teleradiology Services for Third Consecutive Year

January 11, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

EDEN PRAIRIE, Minn., Jan. 11, 2011 /- Virtual Radiologic (vRad), a technology-enabled national radiology practice, has again been ranked "Best in KLAS" in the Teleradiology Services market segment by independent research and consulting firm KLAS. This ranking measures performance based...

Advertisement

CareFusion Announces Sale of OnSite Services Instrument Management and Repair Business

January 11, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Jan. 11, 2011 /- CareFusion (NYSE: CFN ), a leading, global medical device company, today announced that it has signed an agreement to sell its OnSite Services instrument management and repair business to Frazier Healthcare. Financial terms of the agreement were not disclosed....

First Five-Year Outcomes Published on CyberKnife Radiosurgery for Prostate Cancer

January 11, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Jan. 11, 2011 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today the first published five-year outcomes on low risk prostate cancer patients treated with the CyberKnife® Robotic Radiosurgery System . The...

STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million

January 11, 2011 2:35 am | by Bio-Medicine.Org | News | Comments

MONROVIA, Calif., Jan. 11, 2011 /- STAAR Surgical Company (Nasdaq: STAA ), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it expects revenue for the fourth quarter ended December 31, 2010 to exceed $14.2 million. Revenues for...

ASU hosts child health forum in Washington

January 10, 2011 11:34 am | by Arizona State University | News | Comments

The College of Nursing & Health Innovation is joining Arizona State University to host a child health forum on Jan. 20 in Washington, DC.read more

Nopras Technologies, Inc. Achieves ISO 9001:2008 Certification

January 10, 2011 10:35 am | by Bio-Medicine.Org | News | Comments

NOVI, Mich., Jan. 10, 2011 /- Nopras Technologies, Inc., a globally recognized management consulting firm which specializes in services for organizations in the Pharmaceutical, Biotechnology, Medical Device and other FDA regulated industries announced on January 10th, 2011 that it has...

Advertisement

Exergen TemporalScanner Sponsors 'Game Time Temperature' for NFL and College Bowl Games

January 10, 2011 7:36 am | by Bio-Medicine.Org | News | Comments

WATERTOWN, Mass., Jan. 10, 2011 /- Drawing attention to its TemporalScanner™ Temporal Artery Thermometer during flu season, Exergen® Corporation is sponsoring "game-time temperature" for national radio broadcasts of NFL games and the upcoming College Bowl football games. The...

Cardinal Health to Release Second-Quarter Results on Feb. 3

January 10, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

DUBLIN, Ohio, Jan. 10, 2011 /- Cardinal Health plans to release second-quarter financial results for its fiscal 2011 on Thursday, Feb. 3, prior to the opening of trading on the New York Stock Exchange. The company has scheduled a webcast and conference call for Feb. 3 at 8:30 a.m. EST to...

CoreLab Partners Launches Advanced Imaging Application

January 10, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., Jan. 10, 2011 /- CoreLab Partners, Inc , the global entity resulting from the merger between RadPharm, Inc and Medifacts International, has launched a new advanced imaging application named ImagEngine® . "We are pleased to announce the release of our proprietary...

$200M Proton Therapy Centers to Deliver Cancer-Fighting Benefits

January 9, 2011 10:37 pm | by San Diego Business Journal | News | Comments

The battle for future proton therapy market share could shape up to be a highly competitive undertaking in the local health care economy if two projects come to fruition.

Important Information for Betaseron® (interferon beta 1-b) Consumers Regarding Triad Group's Alcohol Prep Products

January 8, 2011 10:35 am | by Bio-Medicine.Org | News | Comments

WAYNE, N.J., Jan. 8, 2011 /-- Bayer HealthCare Pharmaceuticals has become aware of a broad United States market recall of alcohol prep pads, swabs and swabsticks manufactured by the Triad Group and marketed under various brand names.  In the interest of patient safety, Bayer wants to...

Advertisement

EDDA Technology Successfully Installs IQQA®-Liver at Mayo Clinic in Arizona

January 7, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., Jan. 7, 2011 /- EDDA Technology, a leading provider of advanced computer assisted radiology and surgery solutions, announces today the successful commercial installation of its IQQA®-Liver Enterprise product at Mayo Clinic, Scottsdale, AZ. As one of the top...

Enox Biopharma, Inc. to Present at OneMedForum Emerging Company Finance Conference.

January 7, 2011 9:34 am | by Bio-Medicine.Org | News | Comments

VANCOUVER, British Columbia, Jan. 7, 2011 /- Enox Biopharma, Inc. CEO, John C. Rewcastle, Ph.D., will present at the 4th Annual OneMedForum Emerging Company Finance Conference on Wednesday, January 12 at 8:10 AM PST. The conference is being held at the Sir Francis Drake Hotel in San...

Chimerix Commences CMX001 Open-Label Clinical Study for the Treatment of Patients With Life-Threatening or Serious dsDNA Viral Infections

January 7, 2011 5:37 am | by Bio-Medicine.Org | News | Comments

RESEARCH TRIANGLE PARK, N.C., Jan. 7, 2011 /- Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced that patient enrollment has begun in a multicenter, open-label clinical study of CMX001 (the CMX001-350 study) for the treatment of...

WaferGen to Present at OneMedForum San Francisco 2011

January 7, 2011 5:37 am | by Bio-Medicine.Org | News | Comments

FREMONT, Calif., Jan. 7, 2011 /- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS ), a leading developer of state-of-the-art genomic analysis systems, today announced that it will present an overview of the company at the 4th Annual OneMedForum Business Development and Investment...

ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics

January 7, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Jan. 7, 2011 /- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) today announced that it has signed a term sheet to acquire a private company that holds certain rights and know-how to poloxamer-based therapeutics. The term sheet is non-binding on both ADVENTRX and the target...

ADVENTRX Pharmaceuticals Announces Capital Raise of $22.5 Million

January 7, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Jan. 7, 2011 /- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) announced today that it has entered into definitive agreements to sell 8,184,556 units in a registered direct offering to RA Capital Management, certain healthcare-focused investors, and other institutional...

DK Sinopharma, Inc. Reviews its Honors of the Year 2010

January 6, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

XI'AN, China, Jan. 6, 2011 /PRNewswire-Asia-FirstCall/ -- DK Sinopharma, Inc. (OTC Bulletin Board: DKSP ) ("DK Sinopharma" or the "Company") reviewed the honors received in the year of 2010 to celebrate the achievements and successes over the past year. In February 2010, the Company won...

What About Us? The State of Women's Sexual Health in Question

January 6, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

SADDLE BROOK, N.J., Jan. 6, 2011 /- The FDA's nod to a new testosterone gel for men will expand the options they have to address the problems of sexual dysfunction. "So where does this leave women?" asks Rachel Braun Scherl, president of Semprae Laboratories, Inc. The announcement of the...

Cardium to Present at OneMedForum San Francisco 2011 Conference

January 6, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Jan. 6, 2011 /- Cardium Therapeutics (NYSE Amex: CXM ) today announced today that it is scheduled to present at the OneMedForum Finance Conference for Emerging Healthcare and Life Sciences Companies on Tuesday, January 11, 2011 at 3:00 p.m. (PT) at the Sir Francis Drake Hotel...

Solos Endoscopy, Inc. Trends toward Strong Continued Growth in 2011

January 6, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

BOSTON, Jan. 6, 2011 /- Solos Endoscopy, Inc. (Pink Sheets: SNDY ) is pleased to announce that the Company looks towards continued growth in 2011 through new product development, new product sales and the completion of the requirements for its ISO 13485 quality management system (QMS)...

OnePartner selects MobileMD for Health Information Exchange

January 6, 2011 3:36 am | by Bio-Medicine.Org | News | Comments

DUFFIELD, Va. and WARMINSTER, Pa., Jan. 6, 2011 /- OnePartner, LLC selects MobileMD, Inc. for Health Information Exchange (HIE) component of innovative, cost effective, and rapidly deployed Electronic Health Record (EHR) solution. Leveraging popular cloud computing techniques designed...

Echo Therapeutics Receives Funding and Commitment of Approximately $5.5 Million

January 6, 2011 3:36 am | by Bio-Medicine.Org | News | Comments

FRANKLIN, Mass., Jan. 6, 2011 /- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE ), a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading